This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
VALENCIA, Calif., May 27, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing treatments for diabetes, announced today that it will present at upcoming conferences.
Jefferies 2014 Global Healthcare Conference on Monday, June 2, 2014 at 2:30 pm (ET) in New York, New York.
Goldman Sachs 35 th Annual Global Healthcare Conference on Thursday, June 12, 2014 at 11:20 am (PT) at the Terranea Resortin Rancho Palos Verdes, California.
Wells Fargo 2014 Healthcare Conference on Tuesday, June 17, 2014 at 10:00 am (ET) at the InterContinental in Boston, Massachusetts.
Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at
About MannKind Corporation
MannKind Corporation (Nasdaq:MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. Its lead product candidate, AFREZZA
®, is under review by the FDA.
MannKind regularly posts copies of its press releases as well as additional information about MannKind on its website
www.mannkindcorp.com . Interested persons can subscribe on the website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.
CONTACT: Matthew J. Pfeffer
Chief Financial Officer